These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 6196205

  • 1. Somatic H-2Kk variants reveal nonidentity of serological and cytotoxic T cell-defined Kk determinants.
    Vohr HW, Holtkamp B, Rajewsky K.
    Eur J Immunol; 1983 Oct; 13(10):846-51. PubMed ID: 6196205
    [Abstract] [Full Text] [Related]

  • 2. Hapten-specific cytotoxic T cell clones undergo somatic variation of their antigen recognition specificity.
    Weltzien HU, Kempkes B, Jankovic DL, Eichmann K.
    Eur J Immunol; 1986 Jun; 16(6):631-9. PubMed ID: 2424767
    [Abstract] [Full Text] [Related]

  • 3. Restriction fine specificity of long-term, hapten-specific cytotoxic T cell clones: analysis with H-2Kbm-mutant mice and H-2Kb-specific monoclonal antibodies.
    Pircher H, Hämmerling G, Hengartner H.
    Eur J Immunol; 1984 Feb; 14(2):144-52. PubMed ID: 6199212
    [Abstract] [Full Text] [Related]

  • 4. Loss of serological determinants does not affect recognition of H-2Kk target cells by an influenza-specific cytotoxic T cell clone.
    Wraith DC, Holtkamp B, Askonas BA.
    Eur J Immunol; 1983 Sep; 13(9):762-6. PubMed ID: 6193967
    [Abstract] [Full Text] [Related]

  • 5. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA, Ahmed R, Oldstone MB.
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [Abstract] [Full Text] [Related]

  • 6. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. II. Development of syngeneic cytotoxicity in the absence of specific antigenic stimulation.
    Claesson MH, Miller RG.
    J Immunol; 1985 Feb; 134(2):684-90. PubMed ID: 2578160
    [Abstract] [Full Text] [Related]

  • 7. Differential genetic requirements for in vivo and in vitro induction of T-killer and T-suppressor cells in the mutant H-2Kb system and the cross-reactivity of the T-killer clones.
    Brondz BD, Kahn ES, Chervonsky AV, Isakova VR, Apasov SG, Blandova ZK.
    Exp Clin Immunogenet; 1987 Feb; 4(4):211-21. PubMed ID: 2978841
    [Abstract] [Full Text] [Related]

  • 8. Clonal analysis of H-2Kb + TNP recognition by T cells with the use of H-2Kbm mutants and H-2Kb-specific monoclonal antibodies.
    Davignon JL, Guimezanes A, Schmitt-Verhulst AM.
    J Immunol; 1983 Sep; 131(3):1073-9. PubMed ID: 6193173
    [Abstract] [Full Text] [Related]

  • 9. Cross-reactive recognition of mouse cells expressing the bm3 and bm11 mutations within H-2Kb by H-2Kb-restricted herpes simplex virus-specific cytotoxic T lymphocytes.
    Jennings SR.
    J Immunol; 1985 Nov; 135(5):3530-6. PubMed ID: 2413124
    [Abstract] [Full Text] [Related]

  • 10. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
    Stukart MJ, Boes J, Melief CJ.
    J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
    [Abstract] [Full Text] [Related]

  • 11. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A, Kruisbeek AM, Andrysiak PM.
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [Abstract] [Full Text] [Related]

  • 12. Preferential response patterns of cytotoxic T lymphocytes specific for fluorescein isothiocyanate-[FITC] modified autologous cells.
    Arora PK, Levy RB, Shearer GM.
    J Immunol; 1982 Feb; 128(2):551-5. PubMed ID: 6798117
    [Abstract] [Full Text] [Related]

  • 13. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
    Jennings SR, Rice PL, Pan S, Knowles BB, Tevethia SS.
    J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
    [Abstract] [Full Text] [Related]

  • 14. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.
    Altevogt P, Leidig S, Heckl-Oestreicher B.
    Cancer Res; 1984 Nov; 44(11):5305-13. PubMed ID: 6333273
    [Abstract] [Full Text] [Related]

  • 15. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.
    Green WR.
    Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206
    [Abstract] [Full Text] [Related]

  • 16. Molecular localization of allogeneic and self determinants recognized by bulk and clonal populations of cytotoxic T cells.
    Levy RB, Ozato K, Richardson JC, Bluestone JA.
    J Immunol; 1985 Feb; 134(2):677-83. PubMed ID: 2578159
    [Abstract] [Full Text] [Related]

  • 17. Cytolytic T cell hybridomas. III. The antigen specificity and the restriction specificity of cytolytic T cells do not phenotypically mix.
    Haas W, Mathur-Rochat J, Kisielow P, von Boehmer H.
    Eur J Immunol; 1985 Sep; 15(9):963-5. PubMed ID: 2412839
    [Abstract] [Full Text] [Related]

  • 18. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR, Moore LC, Engelhard VH.
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [Abstract] [Full Text] [Related]

  • 19. Growth-dependent variation of major histocompatibility complex (MHC) restriction and expression of Ly-2 and CD3/alpha/beta T cell receptor in cloned cytotoxic T cells.
    Weltzien HU, Kempkes B, Studer R, Melchers I, Eichmann K.
    Eur J Immunol; 1988 Mar; 18(3):431-7. PubMed ID: 2965649
    [Abstract] [Full Text] [Related]

  • 20. Characterization of determinants encoded by four Qa-1 genotypes and their recognition by cloned cytotoxic T lymphocytes.
    Jenkins RN, Rich RR.
    J Immunol; 1983 Nov; 131(5):2147-53. PubMed ID: 6195252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.